A phase I/IIa, single-centre, randomized, double-blind, placebo-controlled, parallel treated dose-ranging study with a safety run-in period to assess the safety and efficacy of topical XZ.700 in patients with mild to moderate atopic dermatitis

Authors
Category Primary study
Registry of TrialsOverview of Medical Research in the Netherlands
Year 2020
This article has no abstract
Epistemonikos ID: 82359975335d61ae55f34fba7cf912d65f59073e
First added on: Apr 11, 2025